stockrow
Monday 9 November 2026
Export IFRX’s income statement to Excel — free account
InflaRx N.V.
IFRXInflaRx N.V.’s revenue for fiscal 2025 (year ended December 2025) was $33,200.00, down 81.5% from fiscal 2024.
- Revenue
- −128.9%
- EPS
- +90.9%
- Free cash flow
- +59.8%
Quarter to September 2026, against a year earlier
1.31
0.05
−3.68%
Follow IFRX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | — | 2,220.94 | |
P/FCF ratio |
— | — | — | 0.00 | |
P/Operating CF |
— | — | — | (16.27) | |
P/B ratio |
— | — | — | 1.45 | |
Price to Tangible BV |
— | — | — | 1.45 | |
EV/Sales |
— | — | — | 411.26 | |
EV/EBITDA |
— | — | — | 0.00 | |
EV/Operating CF |
— | — | — | (0.31) | |
EV/FCF |
— | — | — | (0.31) | |
Quick Ratio |
7.19 | 8.10 | 3.88 | 3.88 | |
Current Ratio |
7.26 | 8.22 | 4.16 | 4.13 | |
Net Debt/EBITDA |
20.72 | 22.35 | 5.77 | 3.28 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.61 | 0.24 | 1.32 | 0.34 | |
Capex/Depreciation |
(0.65) | (0.50) | (0.11) | 0.02 | |
Interest Coverage |
(412.78) | (500.48) | (504.43) | (870.88) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | (15,830.20%) | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | (10,522.34%) | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | (349.24%) | |
Graham Net Nets |
— | — | — | 0.67 | |
Graham Number |
— | — | — | 0.00 | |
Earnings Yield |
— | — | — | (75.25%) | |
Free Cash Flow Yield |
— | — | — | (59.16%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.03) | (0.02) | (0.12) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.03) | (0.12) | (0.06) | |
Cash per Share |
0.93 | 1.60 | 0.69 | 0.82 | |
Shareholders Equity per Share |
1.13 | 1.44 | 0.60 | 0.70 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.13 | 1.44 | 0.60 | 0.70 | |
Free Cash Flow |
(4.59) | (2.99) | (8.66) | (4.17) | |
Working Capital |
120.08 | 168.90 | 42.14 | 45.99 | |
Capital Expenditures |
(0.06) | (0.05) | (0.01) | 0.00 | |
Net Current Asset Value |
119.44 | 168.21 | 41.43 | 45.23 | |
EV/EBIT |
— | — | — | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.05 | |
Price to Operating Income |
— | — | — | 0.00 | |
| Other line items | |||||
Average Receivables |
1.80 | 1.90 | 1.86 | 1.75 | |
Average Payables |
7.74 | 8.61 | 7.24 | 9.22 | |
Average Assets |
130.92 | 138.72 | 74.44 | 72.37 | |
Average Common Equity |
109.45 | 117.36 | 58.71 | 56.74 |
Columns are period end dates · fundamentals updated 5 Nov 2026